HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme
Help Login Register
Market News Stocks News ETF News Crypto News

Kura Oncology, Inc.

Contributing Author

Recent Articles by Kura Oncology, Inc.

3 hours
Kura Oncology and Kyowa Kirin Report Positive Pivotal Ziftomenib Monotherapy Data at 2025 ASCO Annual Meeting KURA +10.72% GlobeNewswire
Jun-01
Kura Oncology and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib in Adults with Relapsed or Refractory NPM1-Mutant AML KURA GlobeNewswire
May-22
Kura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual Meeting KURA GlobeNewswire
May-20
Kura Oncology to Participate in Three Upcoming Investor Conferences KURA GlobeNewswire
May-14
Kura Oncology and Kyowa Kirin Announce Combination Data for Ziftomenib in Oral Presentation at the 2025 European Hematology Association (EHA) Congress KURA GlobeNewswire
May-06
Kura Oncology to Participate in Bank of America Securities Healthcare Conference KURA GlobeNewswire
May-02
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) KURA GlobeNewswire
May-01
Kura Oncology Reports First Quarter 2025 Financial Results KURA GlobeNewswire
Affiliate • Advertise • Theme Settings • Contact • Help • Privacy • Do Not Sell My Data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.

Upgrade your FINVIZ experience

Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.

Learn more about FINVIZ*Elite